Triple modality (neoadjuvant chemoradiotherapy followed by surgical resection): is it better than definitive chemoradiation therapy in cancer of the thoracic esophagus?

Tracey E Schefter, Laurie E Gaspar

Open source

DOI
10.1016/s0360-3016(01)02639-6
Published
2002-02
Container
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0360-3016-01-02639-6,
  title = {Triple modality (neoadjuvant chemoradiotherapy followed by surgical resection): is it better than definitive chemoradiation therapy in cancer of the thoracic esophagus?},
  author = {Tracey E Schefter and Laurie E Gaspar},
  year = {2002},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  doi = {10.1016/s0360-3016(01)02639-6},
  url = {https://doi.org/10.1016/s0360-3016(01)02639-6}
}

RIS

TY  - JOUR
TI  - Triple modality (neoadjuvant chemoradiotherapy followed by surgical resection): is it better than definitive chemoradiation therapy in cancer of the thoracic esophagus?
AU  - Tracey E Schefter
AU  - Laurie E Gaspar
PY  - 2002
JO  - International Journal of Radiation Oncology*Biology*Physics
DO  - 10.1016/s0360-3016(01)02639-6
UR  - https://doi.org/10.1016/s0360-3016(01)02639-6
ER  - 

APA

Schefter, T. E., & Gaspar, L. E. (2002). Triple modality (neoadjuvant chemoradiotherapy followed by surgical resection): is it better than definitive chemoradiation therapy in cancer of the thoracic esophagus?. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/s0360-3016(01)02639-6

Source records